LeonaBio (LONA) Equity Ratio (2019 - 2026)

LeonaBio (LONA) has 8 years of Equity Ratio data on file, last reported at 0.69 in Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.69, down 19.72% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.69 (down 19.72% YoY), and the FY2025 annual result was 0.3, down 60.47% from the prior year.
• Equity Ratio rose to 0.69 in Q1 2026 per LONA's latest filing, from 0.3 in the prior quarter.
• Over five years, Equity Ratio peaked at 0.96 in Q1 2022 and troughed at 0.3 in Q4 2025.
• A 5-year average of 0.82 and a median of 0.86 in 2025 frame the typical range for Equity Ratio.
• On a YoY basis, Equity Ratio climbed as much as 33.58% in 2025 and fell as far as 60.47% in 2025.
• A 5-year view of Equity Ratio shows it stood at 0.91 in 2022, then slipped by 10.8% to 0.81 in 2023, then slipped by 6.1% to 0.76 in 2024, then tumbled by 60.47% to 0.3 in 2025, then jumped by 128.37% to 0.69 in 2026.
• Business Quant data shows LONA's Equity Ratio at 0.69 in Q1 2026, 0.3 in Q4 2025, and 0.89 in Q3 2025.